Inventor · disambiguated record
Xiaojing Wang
Also filed as: WANG XIAOJING · WANG XIAOJING MICHAEL
46 granted patents·23 pending applications·290 citations·filing 1998–2024
98Inventor score
Files withGENENTECH INC28NOVARTIS AG8ISIS PHARMACEUTICALS INC4GILEAD CONNECTICUT INC3NOVARTIS VACCINES & DIAGNOSTIC3
Top patents by PatentIndex Score
69 records- 0197US9980947B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted May 29, 2018·17 cites·87 claims
- 0293US7893039B2Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituentsISIS PHARMACEUTICALS INC·Filed 2008·Granted Feb 22, 2011·42 cites·16 claims
- 0392US10966963B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2018·Granted Apr 6, 2021·10 cites·32 claims
- 0492US9845291B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Dec 19, 2017·15 cites·14 claims
- 0592US8114856B2Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituentsSWAYZE ERIC E·Filed 2011·Granted Feb 14, 2012·22 cites·20 claims
- 0691US9260425B2Pyrazolo[3,4-c]pyridine compounds and methods of useDO STEVEN·Filed 2012·Granted Feb 16, 2016·29 cites·14 claims
- 0790US8618107B2Pyridone and aza-pyridone compounds and methods of useBARBOSA ANTONIO J M·Filed 2011·Granted Dec 31, 2013·24 cites·30 claims
- 0886US8435976B24-substituted pyridin-3-yl-carboxamide compounds and methods of useWANG XIAOJING·Filed 2010·Granted May 7, 2013·5 cites·4 claims
- 0986US6486158B1[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasiaCELL PATHWAYS INC·Filed 2001·Granted Nov 26, 2002·17 cites·33 claims
- 1086US2025114338A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2024·Application pending·0 cites
- 1185US8119654B2Indenoisoquinolinone analogs and methods of use thereofJAGTAP PRAKASH·Filed 2008·Granted Feb 21, 2012·13 cites·43 claims
- 1284US7470701B2Substituted 2,5-heterocyclic derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Dec 30, 2008·11 cites·38 claims
- 1383US10654867B2Heteroaryl estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2019·Granted May 19, 2020·1 cites·5 claims
- 1483US10188649B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 29, 2019·3 cites·4 claims
- 1582US11629149B210-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenzaNOVARTIS AG·Filed 2019·Granted Apr 18, 2023·3 cites·4 claims
- 1682US8569264B2Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituentsSWAYZE ERIC E·Filed 2012·Granted Oct 29, 2013·5 cites·25 claims
- 1782US8377896B2Antibacterial 4,6-substituted 6′, 6″ and 1 modified aminoglycoside analogsISIS PHARMACEUTICALS INC·Filed 2011·Granted Feb 19, 2013·5 cites·14 claims
- 1882US6180629B1[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Jan 30, 2001·28 cites·24 claims
- 1981US8436001B2Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useWANG XIAOJING·Filed 2011·Granted May 7, 2013·5 cites·17 claims
- 2081US8426424B2Certain substituted amides, method of making, and method of use thereofBLOMGREN PETER A·Filed 2009·Granted Apr 23, 2013·5 cites·30 claims
- 2180US9763937B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2015·Granted Sep 19, 2017·3 cites·4 claims
- 2280US9505785B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2013·Granted Nov 29, 2016·3 cites·37 claims
- 2380US9242996B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2014·Granted Jan 26, 2016·5 cites·27 claims
- 2478US9434725B25-azaindazole compounds and methods of useGENENTECH INC·Filed 2013·Granted Sep 6, 2016·4 cites·17 claims
- 2577US10053451B2Heterocyclic estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Aug 21, 2018·2 cites·10 claims
- 2677US2025034156A110-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 ',2':4,5]pyrazino[1,2-B]pyridazine-3,5-dione Derivatives and Related Compounds as Inhibitors of the Orthomyxovirus Replication for Treating InfluenzaNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2776US8669361B2Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useGENENTECH INC·Filed 2013·Granted Mar 11, 2014·2 cites·16 claims
- 2875US8742078B2Antibacterial 4,6-substituted 6′, 6″ and 1 modified aminoglycoside analogsISIS PHARMACEUTICALS INC·Filed 2013·Granted Jun 3, 2014·2 cites·27 claims
- 2974US12071441B210-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenzaNOVARTIS AG·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 3073US8975260B2Pyridazinones, method of making, and method of use thereofCURRIE KEVIN S·Filed 2011·Granted Mar 10, 2015·3 cites·20 claims
- 3172US12233052B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·32 claims
- 3272US9573943B2Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useGENENTECH INC·Filed 2014·Granted Feb 21, 2017·1 cites·17 claims
- 3370US9850239B2Pyrazolo[3,4-c]pyridine compounds and methods of useGENENTECH INC·Filed 2016·Granted Dec 26, 2017·1 cites·14 claims
- 3470US9328106B2Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useGENENTECH INC·Filed 2013·Granted May 3, 2016·1 cites·23 claims
- 3570US2025230147A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 3669US10399939B2Tetrahydronaphthalene estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Sep 3, 2019·1 cites·35 claims
- 3767US10660888B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2018·Granted May 26, 2020·0 cites·6 claims
- 3865US9249123B2Pyridinones/pyrazinones, method of making, and method of use thereofCURRIE KEVIN S·Filed 2011·Granted Feb 2, 2016·1 cites·19 claims
- 3964US12466821B2Antiviral pyridopyrazinedione compoundsNOVARTIS AG·Filed 2021·Granted Nov 11, 2025·0 cites·10 claims
- 4063US10344040B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2018·Granted Jul 9, 2019·0 cites·16 claims
- 4163US10160726B2Quinolone derivatives as antibacterialsNOVARTIS AG·Filed 2015·Granted Dec 25, 2018·1 cites·22 claims
- 4262US2023381155A1Treatment of breast cancer using combination therapies comprising gdc-9545 and gdc-0077GENENTECH INC·Filed 2023·Application pending·0 cites
- 4360US2023381154A1Treatment of breast cancer using combination therapies comprising gdc-9545 and abemaciclib or ribociclibGENENTECH INC·Filed 2023·Application pending·0 cites
- 4460US2023079990A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 4560US2025177318A1Cmt-3 formulations and methods of using the sameUNIV NEW YORK STATE RES FOUND·Filed 2023·Application pending·0 cites
- 4657US12187709B2Lactams as CBL-B inhibitors selective over C-CBLGENENTECH INC·Filed 2022·Granted Jan 7, 2025·0 cites·20 claims
- 4756US10053469B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2016·Granted Aug 21, 2018·0 cites·27 claims
- 4856US2018002344A1Heteroaryl estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4955US11072610B2Antiviral pyridopyrazinedione compoundsNOVARTIS AG·Filed 2019·Granted Jul 27, 2021·0 cites·21 claims
- 5054US2008255120A1Substituted 2,5-heterocyclic derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xiaojing Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →